Medical Research News and Research

RSS

Scientists identify genetic marker to diagnose DFTD

An international team of scientists led by a Cold Spring Harbor Laboratory (CSHL) investigator has discovered that the deadly facial tumors decimating Australia's Tasmanian devil population probably originated in Schwann cells, a type of tissue that cushions and protects nerve fibers.

4 Jan 2010

NFXF applauds the Congress and President for including Fragile X Syndrome for research funding

The National Fragile X Foundation applauds the United States Congress and President Barack Obama for including Fragile X Syndrome for the first time ever within a select group of conditions eligible for research funding from the U.S. Department of Defense.

30 Dec 2009

Achievements in lupus research, education and advocacy cause for celebration and hope

The year 2009 will be remembered as a year of many firsts for lupus, including the first successful phase III clinical trial of a potential new treatment for lupus, the launch of the first-ever Ad Council public awareness campaign for lupus, and the first comprehensive report on the barriers to lupus drug development. And it appears there are no signs of any slowing of momentum as we enter the New Year.

23 Dec 2009

Rigel Pharmaceuticals announces milestone payment from Daiichi Sankyo

Rigel Pharmaceuticals, Inc. today announced that it has received a milestone payment from Daiichi Sankyo Co., Ltd. as part of their collaboration to research and develop cancer treatments aimed at selectively inhibiting ligases, which are intrinsic to cancer cell growth and proliferation. The compound, as yet unnamed, targets cell division.

23 Dec 2009

Australian scientists show connections between brain and regulation of bone mass

The brain acts as a profound regulatory centre, controlling myriad processes throughout the body in ways we are only just beginning to understand. In new findings, Australian scientists have shown surprising connections between the brain and regulation of bone mass.

23 Dec 2009

Guardian Technologies International meets and presents SM TBDx to Indian healthcare officials

Tuberculosis (TB) continues to be a serious global pandemic health threat with more than 9 million new cases diagnosed annually. TB is a leading cause of mortality in India, killing nearly 1,000 people each day.

23 Dec 2009

Veolia Energy North America and Morgan Stanley Infrastructure Partners to acquire MATEP for $320 million

...

22 Dec 2009

Reference platform for diabetic retinopathy and other vascular complications

The volume addresses a variety of current scientific discussions about mechanisms of damage such as growth factors and the VEGF/PEDF balance in the diabetic eye, the ocular renin-angiotensin system, and leukocyte interactions with the microvasculature among others.

22 Dec 2009

Findings may help develop new antiviral drugs for influenza

Investigators at Burnham Institute for Medical Research (Burnham), Mount Sinai School of Medicine (Mount Sinai), the Salk Institute for Biological Studies (Salk) and the Genomics Institute of the Novartis Research Foundation (GNF) have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1.

22 Dec 2009

United States Congress approves additional $15 million in research funding for lung cancer

Today, the United States Congress approved an additional $15 million in research funding for lung cancer as part of the fiscal year 2010 Department of Defense (DOD) Appropriations package.

20 Dec 2009

Distinguished Young Scholars Program completed by W. M. Keck Foundation

The W. M. Keck Foundation, a leading supporter of pioneering medical research, science and engineering, today announced the successful completion of its Distinguished Young Scholars Program, a groundbreaking initiative created to give the nation's most promising young scientists the resources they need to pursue potentially breakthrough research projects in biomedical research.

19 Dec 2009

SAIC receives multiple-award contract to support BUMED throughout the U.S.

Science Applications International Corporation (SAIC) today announced it has been awarded a prime contract by the U.S. Army Research, Development and Engineering Command Acquisition Center - Natick Contracting Division to support the U.S. Navy's Chief Bureau of Medicine and Surgery (BUMED) for Medical Research and Development, and their subordinate research and development commands.

18 Dec 2009

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.

18 Dec 2009

Statistics show China may surpass U.S. in academic output by next decade

Data from a recent Thomson Reuters study show that Chinese research output has increased from just over 20,000 papers in 1998 to nearly 112,000 in 2008.

18 Dec 2009

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

The Hebrew University of Jerusalem Kuvin Center for the Study of Infectious and Tropical Diseases has received a $5 million grant from the Bill & Melinda Gates Foundation for research into visceral leishmaniasis in Ethiopia.

17 Dec 2009

Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased emergency room visits or hospitalizations for epilepsy.

17 Dec 2009

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus -- in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.

17 Dec 2009

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

17 Dec 2009

Arrayit Diagnostics to begin marketing its OvaDx Pre-Symptomatic Ovarian Cancer Blood Test in 2010

John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the Company by Arrayit Corporation.

17 Dec 2009

Human embryonic stem cell lines lack genetic diversity, says study

The most widely used human embryonic stem cell lines lack genetic diversity, a finding that raises social justice questions that must be addressed to ensure that all sectors of society benefit from stem cell advances, according to a University of Michigan research team.

17 Dec 2009

Medical Research News and Research

Scientists identify genetic marker to diagnose DFTD

NFXF applauds the Congress and President for including Fragile X Syndrome for research funding

Achievements in lupus research, education and advocacy cause for celebration and hope

Rigel Pharmaceuticals announces milestone payment from Daiichi Sankyo

Australian scientists show connections between brain and regulation of bone mass

Guardian Technologies International meets and presents SM TBDx to Indian healthcare officials

Veolia Energy North America and Morgan Stanley Infrastructure Partners to acquire MATEP for $320 million

Reference platform for diabetic retinopathy and other vascular complications

Findings may help develop new antiviral drugs for influenza

United States Congress approves additional $15 million in research funding for lung cancer

Distinguished Young Scholars Program completed by W. M. Keck Foundation

SAIC receives multiple-award contract to support BUMED throughout the U.S.

JDRF to work with Johnson & Johnson to develop drug targets and pathways for treating diabetes

Statistics show China may surpass U.S. in academic output by next decade

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

Arrayit Diagnostics to begin marketing its OvaDx Pre-Symptomatic Ovarian Cancer Blood Test in 2010

Human embryonic stem cell lines lack genetic diversity, says study

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News